Navigation Links
FDA Approves Additional Indication for Astellas' MYCAMINE(R)
Date:1/23/2008

(lethal) for Candida.

MYCAMINE is approved for the treatment of patients with Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses; for the treatment of patients with Esophageal Candidiasis and the prophylaxis of Candida Infections in patients undergoing Hematopoietic Stem Cell Transplantation. The efficacy of MYCAMINE against infections caused by fungi other than Candida has not been established. MYCAMINE has not been adequately studied in patients with endocarditis, osteomyelitis and meningitis due to Candida infections.

MYCAMINE can be used concomitantly with a number of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus with no alteration in the pharmacokinetics of MYCAMINE. Patients should be monitored for sirolimus, nifedipine or itraconazole toxicity if receiving these drugs in combination with MYCAMINE and their dosage reduced, if necessary.

MYCAMINE is available in two sizes, 50mg vial and 100mg vial, offering clinicians convenience of use in the administration of the drug, while reducing waste in the hospital setting.

Important Safety Information

MYCAMINE is contraindicated in patients with hypersensitivity to any component of this product or other echinocandins.

Isolated cases of serious hypersensitivity (anaphylaxis and anaphylactoid) reactions (including shock) have been reported in patients receiving MYCAMINE.

Isolated cases of clinically significant hepatic dysfunction, hepatitis, hepatic failure, renal dysfunction, acute renal failure, hemolysis, or hemolytic anemia have occurred in some patients who have received MYCAMINE. Patients who develop these conditions, or abnormal liver or renal function tests, should be monitored for worsening function and evaluated for risk/benefit of continuing MYCAMINE therapy.

Adverse events with MYCAMINE included histamine-mediated symptoms (including rash, pruritus, fac
'/>"/>

SOURCE Astellas Pharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 30, 2015 , ... After conducting a nationwide executive search led by healthcare ... in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh as Chief Executive Officer. Walsh ... healthcare leadership experience, Walsh is an expert in organizational change, physician development, implementation of ...
(Date:7/30/2015)... ... 2015 , ... HEALTHCAREfirst , the leading provider of cloud-based software, services ... hosting a free webinar detailing the 2016 proposed rule from CMS for home health. ... President of Regulatory Affairs for the National Association for Home Care and Hospice (NAHC), ...
(Date:7/30/2015)... Orem, UT (PRWEB) , ... July 30, 2015 , ... When trying to gain weight, many people place a lot ... the amount of calories that need to be consumed. However, another key component to successful ... to gain weight. To assist with this, CB-1 Weight Gainer gives three tips on ...
(Date:7/30/2015)... ... July 30, 2015 , ... World ... women to ensure their children have the nutrition required to grow into healthy ... offering discount cards for many prescription pre-natal vitamins. , Folic Acid , Arguably ...
(Date:7/29/2015)... ... July 30, 2015 , ... Drs. Hamstead are very excited to announce ... therapy to the offerings in the clinic; massage therapy works very well alongside chiropractic ... Crystal Gaines has joined AlignLife of Simpsonville to work alongside the doctors. Many people ...
Breaking Medicine News(10 mins):Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:AlignLife of Simpsonville Hires Massage Therapist 2
... 15 "We believe that hair loss for,both men and ... to find a,non-surgical approach to help our clients that worked ... We selected the Revage 670(TM),because it is the only true ... it works (supported by Harvard Medical, Northwestern,University , Mass ...
... 15 The Musculoskeletal Transplant,Foundation (MTF) announced today ... the,development phase in its efforts to develop a ... Orthofix International N.V. (Nasdaq:, OFIX ). ... package to Orthofix,which confirms the relative superiority of ...
... Dec. 15 DaVita Inc.,(NYSE: DVA ), ... Department of,Health and Human Services, Office of Inspector General ... in connection with the civil,investigation by the Department of ... of Georgia previously reported in the Company,s,Quarterly Report on ...
... COLUMBUS, Ga., Dec. 15 Hundreds of Aflac agents ... have their cheeks swabbed,as part of a new company initiative to ... Aflac,s Bone Marrow program kicks off at the company,s annual,national sales ... The bone marrow registration effort was inspired by Steve ...
... infection than during the day, study says , , MONDAY, Dec. ... a sick body good, new research says. , Stanford University ... invading bacteria the hardest at night and the least during ... the American Society for Cell Biology annual meeting, in San ...
... study suggests , , MONDAY, Dec. 15 (HealthDay News) -- Letting ... a bit later may lower their odds for car crash ... found a 16.5 percent drop in auto accident rates for ... classes from 7:30 a.m. to 8:30 a.m. , The possible ...
Cached Medicine News:Health News:Musculoskeletal Transplant Foundation Announces Major Development Milestone in Stem Cell Allograft Product 2Health News:Musculoskeletal Transplant Foundation Announces Major Development Milestone in Stem Cell Allograft Product 3Health News:DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation 2Health News:Aflac Agents and Employees Boost Bone Marrow Registry 2Health News:Aflac Agents and Employees Boost Bone Marrow Registry 3Health News:Immune System Works Better at Night 2Health News:Later School Start Time Cuts Teens' Car Crash Risk 2Health News:Later School Start Time Cuts Teens' Car Crash Risk 3
(Date:7/30/2015)... Health today reported fourth-quarter fiscal year 2015 revenues ... and non-GAAP diluted earnings per share (EPS) from ... percent. Non-GAAP operating earnings increased 33 percent to ... increased 44 percent to $558 million, and diluted ... $0.88. Fiscal year 2015 revenues increased ...
(Date:7/30/2015)... Ind., July 30, 2015 , Net Sales ... the prior year period and an increase of 5.7% constant ... second quarter was $(0.91), and adjusted earnings per share were ... , Company updates guidance Zimmer Biomet ... for the quarter ended June 30, 2015.  The Company reported ...
(Date:7/29/2015)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today ... Test v2 for Premarket Approval (PMA) to the ... companion diagnostic test for AZD9291, an AstraZeneca investigational ... an acquired resistant mutation.  Patients ... with tumor containing an EGFR sensitizing mutation show ...
Breaking Medicine Technology:Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 2Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 3Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 4Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 5Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 6Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 7Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 8Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 9Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 10Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 11Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 12Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 13Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 14Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 15Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 16Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 17Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 18Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 19Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 20Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 21Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 22Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 23Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 24Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 25Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 26Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 27Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 28Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 29Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 30Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 31Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 32Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 33Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 34Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 35Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 36
... Minn., Nov. 17, 2010 People who are searching ... with less potential for flushing can turn to Slo-Niacin®. ... Slo-Niacin® is a niacin supplement that has been shown ... "Slo-Niacin® features a unique patented polygel® system ...
... Sutro Biopharma today announced that the company has ... financing will support the company,s ongoing development of ... the company,s biochemical protein synthesis platform to meet ... Led by Skyline Ventures, the financing round, ...
Cached Medicine Technology:Slo-Niacin® Dietary Supplement Shown to Support 'Good' Cholesterol (HDL) 2Slo-Niacin® Dietary Supplement Shown to Support 'Good' Cholesterol (HDL) 3Slo-Niacin® Dietary Supplement Shown to Support 'Good' Cholesterol (HDL) 4Sutro Biopharma Secures $36.5 Million in Series C Financing 2
... Viewing System was developed in New ... the surgical supervision of Professor Stanley Chang, ... New York Cornell Medical Center and later ... on the market and immediately revolutionized the ...
... Cadwell's custom bars have a ... solid, machined contacts (spaced 3 centimeters ... tear of repeated cleaning. Polarity indicators ... convenient, snap-on handle fits our bar ...
... The Plume-inator produces the strongest ... of smoke evacuators. The ... button, hospital grade plug, footswitch, ... dual purpose swing ring to ...
... VitalVac's advanced technology makes ... to evacuate surgical plume. ... O.R. environment is "smoke-free", ... staff safe from potentially ...
Medicine Products: